Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphaëlle Toledano Zur

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Experientia Supplementum (2012)|February 15, 2022
Adoptive T-cell Immunotherapy: Perfecting Self-DefensesRaphaëlle Toledano Zur, Galit Adler, Katerina Shamalov, et al.
Frontiers in Immunology|April 4, 2025
Hexokinase2-engineered T cells display increased anti-tumor functionRaphaëlle Toledano Zur, Shiran Didi Zurinam, Maria Radman, et al.
Journal for Immunotherapy of Cancer|July 4, 2024
Genetically engineering glycolysis in T cells increases their antitumor functionRaphaëlle Toledano Zur, Orna Atar, Tilda Barliya, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Experientia Supplementum (2012)|February 15, 2022
Adoptive T-cell Immunotherapy: Perfecting Self-DefensesRaphaëlle Toledano Zur, Galit Adler, Katerina Shamalov, et al.
Frontiers in Immunology|April 4, 2025
Hexokinase2-engineered T cells display increased anti-tumor functionRaphaëlle Toledano Zur, Shiran Didi Zurinam, Maria Radman, et al.
Journal for Immunotherapy of Cancer|July 4, 2024
Genetically engineering glycolysis in T cells increases their antitumor functionRaphaëlle Toledano Zur, Orna Atar, Tilda Barliya, et al.
Pageof 1